Salt Lake City-based NutraNomics (OTC:NNRX) has evolved from its former days as DBA Health Education Corp.
Tuesday, the company announced plans to add a new line of CBD (cannabidiol) products to add to its already successful, existing line of nutraceutical offerings. NNRX seeking strategic partnerships to source raw materials and begin the process of developing, manufacturing and bringing a high-quality CBD product to market.
A news release out Tuesday states that current CBD research has made great strides in dealing with anxiety reduction, depression, heart health, athletic recovery, diabetes prevention as well as assisting in the recovery process for various illnesses and injuries including cancer. NutraNomics will continue on its plan to distribute its products through multiple distribution, manufacturing and marketing agreements thereby continuing its rapid growth.
CEO Jonathan Bishop says, "This is a particularly exciting time for the Company. We have been working diligently and tirelessly to redefine the Company and position it for the growth it is now experiencing."
Shares in NNRX doubled in price Tuesday afternoon to eight-100ths of a cent, on volume topping 221 million shares.
